- Home
- MMA vs INAB Comparison
MMA vs INAB Comparison
Compare MMA & INAB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MMA
- INAB
- Stock Information
- Founded
- MMA 2013
- INAB 2016
- Country
- MMA Australia
- INAB United States
- Employees
- MMA N/A
- INAB N/A
- Industry
- MMA
- INAB Biotechnology: Pharmaceutical Preparations
- Sector
- MMA
- INAB Health Care
- Exchange
- MMA Nasdaq
- INAB Nasdaq
- Market Cap
- MMA 15.9M
- INAB 18.8M
- IPO Year
- MMA 2024
- INAB 2021
- Fundamental
- Price
- MMA $0.93
- INAB $0.16
- Analyst Decision
- MMA
- INAB Strong Buy
- Analyst Count
- MMA 0
- INAB 2
- Target Price
- MMA N/A
- INAB $3.60
- AVG Volume (30 Days)
- MMA 2.6M
- INAB 821.9K
- Earning Date
- MMA 01-21-2025
- INAB 05-08-2025
- Dividend Yield
- MMA N/A
- INAB N/A
- EPS Growth
- MMA N/A
- INAB N/A
- EPS
- MMA N/A
- INAB N/A
- Revenue
- MMA $375,175.00
- INAB N/A
- Revenue This Year
- MMA N/A
- INAB N/A
- Revenue Next Year
- MMA N/A
- INAB N/A
- P/E Ratio
- MMA N/A
- INAB N/A
- Revenue Growth
- MMA 45.19
- INAB N/A
- 52 Week Low
- MMA $0.60
- INAB $0.13
- 52 Week High
- MMA $5.00
- INAB $1.74
- Technical
- Relative Strength Index (RSI)
- MMA N/A
- INAB 35.83
- Support Level
- MMA N/A
- INAB $0.15
- Resistance Level
- MMA N/A
- INAB $0.18
- Average True Range (ATR)
- MMA 0.00
- INAB 0.02
- MACD
- MMA 0.00
- INAB 0.00
- Stochastic Oscillator
- MMA 0.00
- INAB 43.08
About MMA Alta Global Group Limited
Mixed Martial Arts Group Ltd formerly Alta Global Group Ltd is a technology company engaged in the provision and administration of mixed martial arts training programs, and gym programs. It provides subscription-based products and services, offering both B2B SaaS solutions and B2C products and programs, covering online engagement, online content, and immersive in-gym experiences. The company's business units are; Trainalta.com; Mixed Martial Arts.com; and Hype.Co, Mobile Marketing solution. Its Alta Platform serves as a comprehensive solution for martial arts and combat sports, offering a blend of four core products: the Warrior Training Program, UFC Fight Fit Program, Alta Academy, and the Alta Community.
About INAB IN8bio Inc.
IN8bio Inc is a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of gamma-delta T cell product candidates for solid and liquid tumors, by employing allogeneic, autologous, and genetically modified gamma-delta T cells. Its product candidates include INB-400, for the treatment of newly diagnosed glioblastoma, or GBM, INB-100 for the treatment of patients with high-risk leukemias undergoing hematopoietic stem cell transplantation, and other product candidates such as INB-200, INB-300, and INB-500.